Telo Genomics Corp.
TDSGF
$0.04
$0.0119.66%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 7.14% | -7.24% | -28.09% | -43.95% | -21.83% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 0.31% | -3.90% | -14.57% | -22.97% | -10.32% |
| Operating Income | -0.31% | 3.90% | 14.57% | 22.97% | 10.32% |
| Income Before Tax | -1.32% | 2.94% | 15.01% | 23.97% | 10.67% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.32% | 2.94% | 15.01% | 23.97% | 10.67% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.32% | 2.94% | 15.01% | 23.97% | 10.67% |
| EBIT | -0.31% | 3.90% | 14.57% | 22.97% | 10.32% |
| EBITDA | -1.21% | 3.01% | 14.06% | 22.84% | 10.35% |
| EPS Basic | 21.97% | 21.07% | 28.26% | 32.28% | 22.35% |
| Normalized Basic EPS | 22.89% | 21.59% | 28.22% | 31.80% | 22.07% |
| EPS Diluted | 6.36% | 7.02% | 15.90% | 23.86% | 17.97% |
| Normalized Diluted EPS | 22.89% | 21.59% | 28.22% | 31.80% | 22.07% |
| Average Basic Shares Outstanding | 30.60% | 23.04% | 17.07% | 11.30% | 14.37% |
| Average Diluted Shares Outstanding | 30.60% | 23.04% | 17.07% | 11.30% | 14.37% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |